Funding rounds
7 company funding rounds disclosed in the weekly RiseFinder box for Week 43 · 19 October 2026.
- Period
- Weekly
- Window
- 7d
- Rows
- 7
- Data through
- Week 43 · 19 October 2026
01/Weekly box
7 entries
01On its website, the company describes its work as “Our Hybrid Approach ™ pairs an agentic AI platform with advanced human business expertise, yours and ours. For real AI transformation, at scale. Book a…”. Its SEC Form D filed on 2026-10-14 reports US$28,999,988 in securities sold, with a first sale date of 2026-09-21. The amount reflects the securities sales disclosed by the company in this offering at the filing date; it is separate from the offering's target amount and from measures of product traction.
SEC Form D
Open source ↗$29.0m
$29.0m of $29.0m target
On its website, the company describes its work as “Expressable’s model of care also focuses on the most important part of improving children’s speech and language skills: the involvement of their parent or caregiver.…”. Its SEC Form D filed on 2026-10-15 reports US$25,499,994 in securities sold, with a first sale date of 2026-09-30. The amount reflects the securities sales disclosed by the company in this offering at the filing date; it is separate from the offering's target amount and from measures of product traction.
SEC Form D
Open source ↗$25.5m
$25.5m of $35.5m target
On its website, the company describes its work as “The Cybersecurity Platform for IT teams Get multiple layers of protection for your organization with Defendify. Learn about Layered Security Detection Response Minimize risk and…”. Its SEC Form D filed on 2026-10-13 reports US$6,538,000 in securities sold, with a first sale date of 2026-09-29. The amount reflects the securities sales disclosed by the company in this offering at the filing date; it is separate from the offering's target amount and from measures of product traction.
SEC Form D
Open source ↗$6.5m
$6.5m of $6.5m target
On its website, the company describes its work as “Factored engineers embed in your environment, work across your stack, and drive critical engineering through production. Meet An Expert Start Building With Factored Explore Our…”. Its SEC Form D filed on 2026-10-14 reports US$2,499,999 in securities sold, with a first sale date of 2026-09-24. The amount reflects the securities sales disclosed by the company in this offering at the filing date; it is separate from the offering's target amount and from measures of product traction.
SEC Form D
Open source ↗$2.5m
$2.5m of $2.5m target
On its website, the company describes its work as “SAAZ is a deep-tech R D company creating novel imaging products and solving complex challenges in imaging technology. We create innovative products that serve military,…”. Its SEC Form D filed on 2026-10-13 reports US$1,500,000 in securities sold, with a first sale date of 2026-08-11. The amount reflects the securities sales disclosed by the company in this offering at the filing date; it is separate from the offering's target amount and from measures of product traction.
SEC Form D
Open source ↗$1.5m
$1.5m of $5.0m target
On its website, the company describes its work as “Keep patients engaged in your system, capture every activity, and unlock new revenue with a single platform that integrates directly into your existing workflows. Become…”. Its SEC Form D filed on 2026-10-13 reports US$1,291,364 in securities sold, with a first sale date of 2026-10-01. The amount reflects the securities sales disclosed by the company in this offering at the filing date; it is separate from the offering's target amount and from measures of product traction.
SEC Form D
Open source ↗$1.3m
$1.3m of $1.5m target
On its website, the company describes its work as “Technologies Seno Vax™ Autologous Approach To Eliminate Senescent Cells More About SenoVax™ StemCell Revivify™ Rebuild Damaged Organs and Tissues With Stem Cells More About StemCellRevivify™…”. Its SEC Form D filed on 2026-10-16 reports US$612,503 in securities sold, with a first sale date of 2024-11-05. The amount reflects the securities sales disclosed by the company in this offering at the filing date; it is separate from the offering's target amount and from measures of product traction.
SEC Form D
Open source ↗$613k
$613k of $5.0m target
This dated edition is generated from the reviewed RiseFinder export. Movement figures retain their original source, period and direction.
02/Get email updates
Join the list
Get early signals on the websites, apps, repositories and startups gaining momentum. Join the list for Risefinder email briefings.
By subscribing, you ask us to store your email and send Risefinder updates. You can unsubscribe at any time. Privacy.
Want a sample first? Read past daily emails.